Dr. Paul S. Teirstein, MD

Dr. Teirstein practices at Scripps Memorial Hospital La Jolla in La Jolla, California, part of Scripps Health.

Dr. Teirstein's NPI, 1548210768, was assigned on May 10, 2006. Dr. Teirstein graduated from Icahn School Of Medicine At Mount Sinai in 1980. Dr. Teirstein holds California license G52018.

Dr. Teirstein's primary practice is Scripps Memorial Hospital La Jolla, at 9888 Genesee Avenue, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 626-4123.

Dr. Teirstein's primary practice is Scripps Memorial Hospital La Jolla in La Jolla, California, part of Scripps Health. Dr. Teirstein is also affiliated with Scripps Memorial Hospital Encinitas. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Teirstein to 1 more hospital and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Teirstein practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Teirstein's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Teirstein is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Teirstein's licenses on file in 2 states: California and New York.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Teirstein treats.

CMS data shows 2,209 Medicare services from Dr. Teirstein across 25 procedure codes in 2024, for 438 Medicare patients. Medicare paid $328,266 for them.

CMS counts 438 Medicare patients who saw Dr. Teirstein in 2024. The largest group is 75 to 84, with 200 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Teirstein's median patient age at 75, with 29% women.

In 2024, Dr. Teirstein wrote 17 Medicare Part D claims. 82% of them were for generic drugs. They cover 2 drugs, with $6,824 in total drug cost. In 2020, CMS named 244 claims across 4 drugs.

Dr. Teirstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 274 procedures of coronary angioplasty and stenting by Dr. Teirstein, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 157 papers to Dr. Teirstein, published from 2003 to 2024. 2014 was the busiest year, with 7. The most frequent topics are Angioplasty, Balloon, Coronary, Stents and Coronary Angiography. Dr. Teirstein has published most often in Am J Cardiol. Dr. Teirstein's most frequent co-authors are Jeffrey Warren Moses, MD, Matthew J. Price, MD and Richard A. Schatz, MD.

Dmand AI links Dr. Teirstein to 10 clinical trials, 2 of them phase 4 studies. 5 are still active or recruiting. Conditions studied include Ventricular Outflow Obstruction, Aortic Valve Stenosis and Coronary Restenosis. Medtronic Cardiovascular sponsors the most, 3.

CMS Open Payments shows 1,330 general payments to Dr. Teirstein from 59 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Medtronic Vascular, Inc. paid the most, $233,054.

Dmand AI lists 6 awards for Dr. Teirstein, most recently America's Top Doctors in 2014.

Dr. Teirstein graduated from Icahn School Of Medicine At Mount Sinai in 1980. Dr. Teirstein is a member of ACC.

Dr. Teirstein is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.